Growth Metrics

Anavex Life Sciences (AVXL) Non-cash Items (2014 - 2025)

Anavex Life Sciences recorded quarterly Non-cash Items of $4.8 million in Q4 2025, down 99.99% quarter-over-quarter from $39.7 billion in Q3 2025, and down 29.41% year-over-year from $6.8 million in Q4 2024.

Anavex Life Sciences' Non-cash Items history runs 12 years deep, the most recent figure standing at $4.8 million for Q4 2025.

  • In Q4 2025, Non-cash Items fell 29.41% year-over-year to $4.8 million; the TTM figure through Dec 2025 stood at $4.8 million (down 29.41% YoY), while the FY2025 annual figure was $10.4 million, up 5.12% from the prior year.
  • Non-cash Items came in at $4.8 million for Q4 2025 at Anavex Life Sciences, down from $39.7 billion in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $39.7 billion in Q3 2025 to a low of $4.8 million in Q4 2025.
  • A 5-year average of $2.1 billion and a median of $10.3 million in 2025 frame the typical range for Non-cash Items.
  • Across the five-year window, Non-cash Items tumbled 64.2% in 2023 and soared 250854.96% in 2025, its largest moves.
  • Anavex Life Sciences' Non-cash Items stood at $18.2 million in 2021, then dropped by 10.07% to $16.3 million in 2022, then tumbled by 40.86% to $9.7 million in 2023, then slipped by 29.63% to $6.8 million in 2024, then slipped by 29.41% to $4.8 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods registered $4.8 million, $39.7 billion, and $10.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Anavex Life Sciences 266.20 Mn 134.45 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 4.80 Mn
Dec 31, 2025 4.80 Mn
Sep 30, 2025 39.72 Bn
Sep 30, 2025 39.72 Bn
Jun 30, 2025 10.54 Mn
Jun 30, 2025 10.54 Mn
Mar 31, 2025 10.35 Mn
Mar 31, 2025 10.35 Mn
Dec 31, 2024 6.80 Mn
Dec 31, 2024 6.80 Mn
Sep 30, 2024 15.83 Mn
Sep 30, 2024 15.83 Mn
Mar 31, 2024 9.96 Mn
Mar 31, 2024 9.96 Mn
Dec 31, 2023 9.66 Mn
Dec 31, 2023 9.66 Mn
Sep 30, 2023 22.29 Mn
Sep 30, 2023 22.29 Mn
Jun 30, 2023 10.03 Mn
Jun 30, 2023 10.03 Mn
Mar 31, 2023 21.78 Mn
Mar 31, 2023 21.78 Mn
Dec 31, 2022 16.34 Mn
Dec 31, 2022 16.34 Mn
Sep 30, 2022 62.27 Mn
Sep 30, 2022 62.27 Mn
Jun 30, 2022 8.56 Mn
Jun 30, 2022 8.56 Mn
Mar 31, 2022 8.20 Mn
Mar 31, 2022 8.20 Mn
Dec 31, 2021 18.17 Mn
Dec 31, 2021 18.17 Mn
Sep 30, 2021 140.13 Mn
Sep 30, 2021 140.13 Mn
Jun 30, 2021 7.93 Mn
Jun 30, 2021 7.93 Mn
Mar 31, 2021 7.09 Mn
Mar 31, 2021 7.09 Mn
Dec 31, 2020 8.19 Mn
Dec 31, 2020 8.19 Mn
Sep 30, 2020 14.98 Mn
Sep 30, 2020 14.98 Mn
Jun 30, 2020 17.82 Mn
Jun 30, 2020 17.82 Mn
Mar 31, 2020 4.52 Mn
Mar 31, 2020 4.52 Mn
Dec 31, 2019 5.88 Mn
Dec 31, 2019 5.88 Mn
Sep 30, 2019 4.12 Mn
Sep 30, 2019 4.12 Mn
Jun 30, 2019 5.46 Mn
Jun 30, 2019 5.46 Mn
Mar 31, 2019 5.24 Mn
Mar 31, 2019 5.24 Mn
Dec 31, 2018 4.36 Mn
Dec 31, 2018 4.36 Mn
Sep 30, 2018 2.35 Mn
Sep 30, 2018 2.35 Mn
Jun 30, 2018 162,500.00
Jun 30, 2018 162,500.00
Mar 31, 2018 3.78 Mn
Mar 31, 2018 3.78 Mn
Dec 31, 2017 1.65 Mn
Dec 31, 2017 1.65 Mn
Sep 30, 2017 5.28 Mn
Sep 30, 2017 5.28 Mn
Jun 30, 2017 630.00
Jun 30, 2017 630.00
Mar 31, 2017 2.61 Mn
Mar 31, 2017 2.61 Mn
Dec 31, 2016 36,000.00
Dec 31, 2016 36,000.00
Sep 30, 2016 2.29 Mn
Sep 30, 2016 2.29 Mn
Jun 30, 2016 217,500.00
Jun 30, 2016 217,500.00
Mar 31, 2016 5.57 Mn
Mar 31, 2016 5.57 Mn
Dec 31, 2015 843,107.00
Dec 31, 2015 843,107.00
Sep 30, 2015 825,002.00
Sep 30, 2015 825,002.00
Sep 30, 2014 525,000.00
Sep 30, 2014 525,000.00